Knowing when a claim could benefit from a referral to field case management can be complicated. In this video, we have outlined key medical considerations that can guide your decision-making. If any of these factors apply to your claim, it may be time to make a referral. Our expert staff of case managers is here to help facilitate timely and appropriate medical care while coordinating a safe and timely return to work.
The COVID-19 pandemic has brought the discussion of presumption laws to the forefront, as states examine whether workers’ compensation should cover workers if they contract COVID-19 on the job. Many states have passed legislation or executive orders requiring insurers to cover essential workers who test positive for the virus. Depending on the state, the definition of “essential worker” might be limited to just healthcare and frontline workers, or it may include a wide range of occupations.
The benefits that workers’ comp networks bring to employees, employers, and providers are clear. What’s most interesting is how networks are evolving to meet the needs of employers and patients. These next-generation networks often are tighter, specialty-focused, smaller — right-sized — networks that benefits providers by grouping together the best of the best.
Some studies estimate that more than half of the workforce is working from home amidst the COVID-19 crisis, and many companies have already announced plans to allow employees to work remotely even after the threat of the virus has subsided. While working from home has helped social distancing efforts across the country, it has also opened up companies to an onslaught of new security threats.
The global response to the coronavirus has affected all aspects of the claims ecosystem, revealing three early indicators that may have a long-lasting impact.
Kentucky delays medical treatment guidelines implementation and Texas suspends elective surgeries in some counties.
The California Division of Workers' Compensation (DWC) recently published a long-awaited draft pharmaceutical fee schedule rule.